Watson Laboratories, Inc. clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., Aug 2, 2016 · source ↗
The registry lists 1 studies whose lead sponsor is Watson Laboratories, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 11, 2013.
- 1study on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Watson Laboratories, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- 1
- First submitted after Watson Laboratories, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Watson Laboratories, Inc.’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Benzoyl Peroxide1 in phase 30 open · 1
- Clindamycin1 in phase 30 open · 1
- clindamycin phosphate1 in phase 30 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Phase
- Phase 31
Over the years
- 112
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Watson Laboratories, Inc.1 study
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Teva Pharmaceutical Industries, Ltd. studies →
- Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne VulgarisCompletedNCT01788384Phase 3
Sponsor listed in the registry: Watson Laboratories, Inc. · First submitted before Watson Laboratories, Inc. became part of Teva Pharmaceutical Industries, Ltd.